title: Evidence for a common endocannabinoid-related pathomechanism in autism spectrum disorders.
abstract: In this issue of Neuron, Földy et al. (2013) report that endocannabinoid-mediated signaling at inhibitory synapses is dysregulated in mouse models of autism-associated Neuroligin-3 mutations. These findings carry implications regarding the pathophysiology of autism spectrum disorders and the development of treatment strategies.
authors.affiliation: Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany. krueger@em.mpg.de
authors.forename: Dilja D
authors.initials: DD
authors.lastname: Krueger
authors.forename: Nils
authors.initials: N
authors.lastname: Brose